A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK

類似資料

• Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China
  著者:: Yan Xu, 等
  出版事項: (2023-12-01)
• Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
  著者:: Ana Florea, 等
  出版事項: (2022-12-01)
• Mumps, Measles and Rubella Vaccination and Encephalitis
  著者:: J Gordon Millichap
  出版事項: (1989-09-01)
• Sex-differential non-vaccine specific immunological effects of diphtheria-tetanus-pertussis and measles vaccination
  著者:: Noho-Konteh, F, 等
  出版事項: (2016)
• Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study
  著者:: Martina Kovac, 等
  出版事項: (2018-08-01)